US Broker Ratings

Quest Diagnostics (DGX) Stock Analysis: Navigating Healthcare Growth with a 2.5% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a cornerstone in the healthcare sector, stands as a formidable player in the diagnostics and research industry. With a commendable market capitalization of $20.53 billion,..

Eli Lilly (LLY) Stock Analysis: Exploring the 17.60% Upside Potential for Investors

Eli Lilly and Company (NYSE: LLY) stands as a towering presence in the healthcare sector, boasting a market capitalization of $674.13 billion. With a rich history dating back to 1876,..

Haleon plc (HLN) Stock Analysis: Exploring a 26.99% Potential Upside with Strong Analyst Ratings

For individual investors seeking exposure in the healthcare sector, Haleon plc (HLN) presents an intriguing opportunity. With a market capitalization of $41.43 billion, this UK-based company is a prominent player..

BioNTech SE (BNTX) Stock Analysis: Exploring a 42.16% Potential Upside Amidst Robust Growth Prospects

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has recently captured the attention of investors with its promising pipeline of immunotherapies targeting cancer and infectious diseases. Based..

Doximity, Inc. (DOCS) Investor Outlook: A Healthcare Innovator with Strong Analyst Support

Doximity, Inc. (DOCS) has captured the attention of individual investors and industry analysts alike with its innovative approach to health information services. As a digital platform catering to medical professionals,..

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 13% Upside Potential in the Diagnostics Sector

Qiagen N.V. (NYSE: QGEN), a leader in the healthcare sector specializing in diagnostics and research, has captured investor attention with its potential upside of 13.04%, according to recent analyst ratings...

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating Growth with a 2.29% Upside Potential

Mettler-Toledo International, Inc. (NYSE: MTD), a stalwart in the Healthcare sector, specifically in Diagnostics & Research, presents an intriguing proposition for investors. With a market capitalization of $26.07 billion, this..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Tenet Healthcare Corporation (THC) Stock Analysis: Navigating Growth with a Strong 29.65% ROE

Tenet Healthcare Corporation (NYSE: THC), a prominent entity in the medical care facilities industry, holds a significant position in the U.S. healthcare sector. With a market capitalization of $16.8 billion,..

Smith & Nephew SNATS, Inc. (SNN) Valuation Insights: Healthcare Giant with a 1.57% Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, is carving a niche for itself in the medical devices industry. Headquartered in Watford, United Kingdom,..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Unlocking a 23.96% Potential Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $18.33 billion, the..

Cencora, Inc. (COR) Stock Analysis: Exploring 14.77% Potential Upside and Robust Revenue Growth

Investors eyeing the healthcare sector might find a compelling opportunity in Cencora, Inc. (NYSE: COR), a prominent player in the medical distribution industry. With a market cap of $56.23 billion,..

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating the 10.38% Potential Upside for Investors

Investors with an eye on the biotechnology sector should closely consider Exelixis, Inc. (NASDAQ: EXEL), a significant player in the oncology market with a steadfast commitment to pioneering cancer treatments...

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 15% Upside Potential Amidst Analyst Consensus

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, is garnering significant attention from investors seeking opportunities in the medical care facilities industry. With a market..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a Potential 11.79% Upside with Strong Buy Ratings

United Therapeutics Corporation (NASDAQ: UTHR) has been capturing investor attention with its robust performance metrics and promising analyst ratings. As a leading biotechnology company, UTHR specializes in addressing critical medical..

Revvity, Inc. (RVTY) Stock Analysis: Discover Its 34.34% Potential Upside

Revvity, Inc. (NYSE: RVTY) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $10.07 billion, this U.S.-based company..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 11.51% Upside Potential

argenx SE (ARGX) is making waves in the biotech industry with a robust pipeline of therapies aimed at tackling some of the most challenging autoimmune diseases. Founded in 2008 and..

Bristol-Myers Squibb (BMY) Stock Analysis: A Closer Look at Its 17.73% Potential Upside

Bristol-Myers Squibb Company (NYSE: BMY) continues to attract investor attention with its robust portfolio of biopharmaceutical products and a potential upside of 17.73% based on current analyst ratings. The company,..

Waters Corporation (WAT) Stock Analysis: A Healthcare Giant with 15.38% Upside Potential

Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector, particularly within the Diagnostics & Research industry, presents an intriguing opportunity for investors seeking exposure to cutting-edge analytical technology..

CVS Health Corporation (CVS) Stock Analysis: Navigating a 10% Potential Upside Amidst Robust Buy Ratings

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector with a market capitalization of $95.02 billion. As a leading provider of health solutions in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds